PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-7.48%
Negative revenue growth while 2127.T stands at 6.63%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-7.46%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-24.95%
Negative EBIT growth while 2127.T is at 3.05%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-28.32%
Negative operating income growth while 2127.T is at 0.01%. Joel Greenblatt would press for urgent turnaround measures.
-25.47%
Negative net income growth while 2127.T stands at 2.15%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-25.47%
Negative EPS growth while 2127.T is at 2.14%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-25.47%
Negative diluted EPS growth while 2127.T is at 3.66%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.00%
Share reduction while 2127.T is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.00%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
56.07%
10Y revenue/share CAGR under 50% of 2127.T's 526.44%. Michael Burry would suspect a lasting competitive disadvantage.
64.73%
5Y revenue/share CAGR under 50% of 2127.T's 179.70%. Michael Burry would suspect a significant competitive gap or product weakness.
32.48%
3Y revenue/share CAGR similar to 2127.T's 33.83%. Walter Schloss would assume both companies experience comparable short-term cycles.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
126.36%
Below 50% of 2127.T's 673.65%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
101.74%
5Y net income/share CAGR at 50-75% of 2127.T's 169.37%. Martin Whitman might see a shortfall in operational efficiency or brand power.
77.60%
3Y net income/share CAGR above 1.5x 2127.T's 36.72%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
195.62%
Below 50% of 2127.T's 684.29%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
123.30%
5Y equity/share CAGR at 50-75% of 2127.T's 176.31%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
57.64%
3Y equity/share CAGR at 50-75% of 2127.T's 106.13%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
266.67%
5Y dividend/share CAGR above 1.5x 2127.T's 173.68%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
144.44%
3Y dividend/share CAGR above 1.5x 2127.T's 52.94%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-3.70%
Firm’s AR is declining while 2127.T shows 12.97%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
5.46%
Inventory shrinking or stable vs. 2127.T's 38.45%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
-0.01%
Negative asset growth while 2127.T invests at 19.25%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
3.68%
Under 50% of 2127.T's 15.83%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-5.56%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
0.60%
We expand SG&A while 2127.T cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.